chr12-112987054-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000392583.7(OAS2):c.194G>A(p.Arg65Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000031 in 1,611,022 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000392583.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OAS2 | NM_002535.3 | c.194G>A | p.Arg65Gln | missense_variant | 2/10 | ENST00000392583.7 | NP_002526.2 | |
OAS2 | NM_016817.3 | c.194G>A | p.Arg65Gln | missense_variant | 2/11 | NP_058197.2 | ||
OAS2 | NM_001032731.2 | c.194G>A | p.Arg65Gln | missense_variant | 2/2 | NP_001027903.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OAS2 | ENST00000392583.7 | c.194G>A | p.Arg65Gln | missense_variant | 2/10 | 1 | NM_002535.3 | ENSP00000376362 | P2 | |
ENST00000552784.1 | n.353+30345C>T | intron_variant, non_coding_transcript_variant | 4 |
Frequencies
GnomAD3 genomes AF: 0.0000526 AC: 8AN: 152146Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000319 AC: 8AN: 250746Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135522
GnomAD4 exome AF: 0.0000288 AC: 42AN: 1458876Hom.: 0 Cov.: 30 AF XY: 0.0000248 AC XY: 18AN XY: 725094
GnomAD4 genome AF: 0.0000526 AC: 8AN: 152146Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74334
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 22, 2024 | The c.194G>A (p.R65Q) alteration is located in exon 2 (coding exon 2) of the OAS2 gene. This alteration results from a G to A substitution at nucleotide position 194, causing the arginine (R) at amino acid position 65 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at